Joshua S. Prince - 31 Dec 2024 Form 4 Insider Report for Vistagen Therapeutics, Inc. (VTGN)

Role
Chief Operating Officer
Signature
/s/ Cynthia Anderson, Attorney-in-Fact
Issuer symbol
VTGN
Transactions as of
31 Dec 2024
Net transactions value
+$8,300
Form type
4
Filing time
13 Jan 2025, 17:40:58 UTC
Previous filing
02 Jul 2024
Next filing
25 Jun 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction VTGN Common Stock Award $8,300 +3,310 +124% $2.51 5,981 31 Dec 2024 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Reporting Person is voluntarily reporting the acquisition of shares under the Issuer's 2019 Employee Stock Purchase Plan, as amended, in a transaction exempt under Rule 16b-3(c) and Rule 16b-3(d).